From: Pregnancy outcomes and neonatal thyroid function in women with thyroid cancer: a retrospective study
Variables | Thyroid cancer (n = 212) | Control group (n = 35,641) | P value |
---|---|---|---|
Age, years | 32.8 (30.2, 35.4) | 31.4 (28.9, 34.5) | < 0.001 |
Multiparity, n (% of pregnancies) | 62 (29.2%) | 11,252 (31.6%) | 0.466 |
History of abnormal pregnancy a, n (% of pregnancies) | 41 (19.3%) | 4165 (11.7%) | 0.001 |
Pre-pregnancy BMI, kg/m2 | 22.0 (20.1, 24.4) | 21.2 (19.5, 23.4) | < 0.001 |
Pre-pregnancy hypertension, n (% of pregnancies) | 5 (2.4%) | 222 (0.6%) | 0.012 |
Pre-pregnancy DM, n (% of pregnancies) | 1 (0.5%) | 162 (0.5%) | 0.382 |
History of PCOS, n (% of pregnancies) | 5 (2.4%) | 1449 (4.1%) | 0.209 |
History of HDP, n (% of multiparity) | 3 (4.8%) | 437 (3.9%) | 0.735 |
History of GDM, n (% of multiparity) | 6 (9.7%) | 883 (7.8%) | 0.632 |
Family history of hypertension, n (% of pregnancies) | 55 (25.9%) | 6536 (18.3%) | 0.004 |
Family history of DM, n (% of pregnancies) | 32 (15.1%) | 4092 (11.5%) | 0.100 |
Conceived by IVF-ET, n (% of pregnancies) | 11 (5.2%) | 1635 (4.6%) | 0.677 |
Thyroid function during early pregnancy | Â | Â | Â |
 TSH, µIU/mL  FT4, pmol/L  TPOAb positive, n (% of pregnancies) | 0.87 (0.30, 1.70) 17.16 (15.62, 19.11) 53 (25.0%) | 1.20 (0.67, 1.87) 15.48 (14.22, 16.93) 4190 (11.8%) | < 0.001 < 0.001 < 0.001 |